|
|
Volumn 332, Issue 6033, 2011, Pages 1020-1021
|
|
Regulatory T cells get their chance to shine
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INSULIN;
INTERLEUKIN 2;
BIOCHEMISTRY;
BLOOD;
MOLECULAR ANALYSIS;
ANTIGEN SPECIFICITY;
CLINICAL EFFECTIVENESS;
DIABETES CONTROL;
GRAFT RECIPIENT;
GRAFT VERSUS HOST REACTION;
HEALTH CARE COST;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
KIDNEY GRAFT REJECTION;
LYMPHOCYTE TRANSFER;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PATIENT SAFETY;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
SHORT SURVEY;
STEM CELL TRANSPLANTATION;
CLINICAL TRIAL (TOPIC);
GRAFT REJECTION;
IMMUNOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
NOTE;
TRANSPLANTATION;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 1;
GRAFT REJECTION;
GRAFT VS HOST DISEASE;
HUMANS;
IMMUNOSUPPRESSION;
KIDNEY TRANSPLANTATION;
T-LYMPHOCYTES, REGULATORY;
|
|
EID: 79957602397
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.332.6033.1020 Document Type: Short Survey |
|
Times cited : (54)
|
|
References (0)
|
